GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.374
-0.026 (-6.45%)
At close: Feb 21, 2025, 4:00 PM
0.368
-0.006 (-1.58%)
After-hours: Feb 21, 2025, 7:59 PM EST
GlucoTrack Employees
GlucoTrack had 6 employees as of December 31, 2023. The number of employees increased by 3 or 100.00% compared to the previous year.
Employees
6
Change (1Y)
3
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,485,833
Market Cap
3.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
GCTK News
- 18 days ago - Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering - GlobeNewsWire
- 18 days ago - Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - GlobeNewsWire
- 24 days ago - Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer - GlobeNewsWire
- 4 weeks ago - Glucotrack Announces ISO 13485:2016 Certification - GlobeNewsWire
- 5 weeks ago - Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs - GlobeNewsWire
- 6 weeks ago - Glucotrack to Present at TechBio Showcase™ 2025 - GlobeNewsWire
- 2 months ago - GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR - GlobeNewsWire
- 3 months ago - Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt - GlobeNewsWire